Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BVS NASDAQ:ESTA NASDAQ:IRTC NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$11.56-4.2%$9.80$5.81▼$12.30$1.01B0.65683,636 shs530,143 shsESTAEstablishment Labs$86.59-1.5%$79.01$33.35▼$92.83$2.59B1.06776,140 shs317,619 shsIRTCiRhythm Technologies$112.55-5.2%$114.76$100.85▼$212.00$3.90B1.27611,941 shs540,711 shsWRBYWarby Parker$27.65+0.9%$26.64$14.96▼$31.00$2.94B1.913.39 million shs2.09 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-4.23%+0.61%+35.84%+9.47%+1,155,999,900.00%ESTAEstablishment Labs-1.49%-4.97%+5.42%+30.00%+90.18%IRTCiRhythm Technologies-5.17%-10.02%-0.97%-9.53%-18.98%WRBYWarby Parker+0.66%-1.51%+5.03%+17.01%+20.13%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$11.56-4.2%$9.80$5.81▼$12.30$1.01B0.65683,636 shs530,143 shsESTAEstablishment Labs$86.59-1.5%$79.01$33.35▼$92.83$2.59B1.06776,140 shs317,619 shsIRTCiRhythm Technologies$112.55-5.2%$114.76$100.85▼$212.00$3.90B1.27611,941 shs540,711 shsWRBYWarby Parker$27.65+0.9%$26.64$14.96▼$31.00$2.94B1.913.39 million shs2.09 million shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus-4.23%+0.61%+35.84%+9.47%+1,155,999,900.00%ESTAEstablishment Labs-1.49%-4.97%+5.42%+30.00%+90.18%IRTCiRhythm Technologies-5.17%-10.02%-0.97%-9.53%-18.98%WRBYWarby Parker+0.66%-1.51%+5.03%+17.01%+20.13%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 3.00Buy$14.7527.60% UpsideESTAEstablishment Labs 2.67Moderate Buy$89.713.61% UpsideIRTCiRhythm Technologies 2.94Moderate Buy$187.3866.49% UpsideWRBYWarby Parker 2.67Moderate Buy$29.827.85% UpsideCurrent Analyst Ratings BreakdownLatest BVS, IRTC, WRBY, and ESTA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026ESTAEstablishment Labs BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/8/2026ESTAEstablishment Labs CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$76.00 ➝ $92.006/30/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$14.006/29/2026WRBYWarby Parker Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$33.006/24/2026ESTAEstablishment Labs Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/22/2026IRTCiRhythm Technologies BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$185.006/18/2026IRTCiRhythm Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/16/2026BVSBioventus Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.006/10/2026IRTCiRhythm Technologies BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$185.006/8/2026ESTAEstablishment Labs TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/2/2026BVSBioventus Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)(Data available from 7/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$576.30M1.68$1.22 per share9.46$2.76 per share4.19ESTAEstablishment Labs$211.08M12.07N/AN/A$0.81 per share106.90IRTCiRhythm Technologies$747.14M4.95N/AN/A$4.74 per share23.74WRBYWarby Parker$871.91M3.40$0.63 per share43.57$3.48 per share7.95Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus$22.73M$0.4128.2012.991.544.94%29.97%9.52%N/AESTAEstablishment Labs-$51.06M-$1.49N/A618.50N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)IRTCiRhythm Technologies-$44.55M-$0.86N/A85.92N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)WRBYWarby Parker$1.64M$0.021,383.1469.125.480.15%2.30%1.18%8/6/2026 (Estimated)Latest BVS, IRTC, WRBY, and ESTA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026ESTAEstablishment Labs-$0.34N/AN/AN/A$65.79 millionN/A8/6/2026Q2 2026WRBYWarby Parker$0.12N/AN/AN/A$237.98 millionN/A7/30/2026Q2 2026IRTCiRhythm Technologies-$0.01N/AN/AN/A$219.29 millionN/A5/7/2026Q1 2026ESTAEstablishment Labs-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million5/7/2026Q1 2026WRBYWarby Parker$0.11$0.03-$0.08$0.03$239.44 million$242.45 million5/6/2026Q1 2026BVSBioventus$0.09$0.15+$0.06$0.04N/A$132.09 million4/30/2026Q1 2026IRTCiRhythm Technologies-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.081.691.13ESTAEstablishment Labs16.822.961.91IRTCiRhythm Technologies4.035.174.98WRBYWarby ParkerN/A2.332.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%ESTAEstablishment Labs72.91%IRTCiRhythm TechnologiesN/AWRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipBVSBioventus33.50%ESTAEstablishment Labs9.99%IRTCiRhythm Technologies0.98%WRBYWarby Parker16.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20083.54 million55.55 millionN/AESTAEstablishment Labs1,00429.43 million26.49 millionOptionableIRTCiRhythm Technologies2,40032.86 million32.54 millionOptionableWRBYWarby Parker4,036107.09 million89.10 millionOptionableBVS, IRTC, WRBY, and ESTA HeadlinesRecent News About These CompaniesNeil Harris Blumenthal Sells 9,200 Shares of Warby Parker (NYSE:WRBY) StockJuly 9, 2026 | insidertrades.comWarby Parker (NYSE:WRBY) CEO Neil Harris Blumenthal Sells 9,200 SharesJuly 8, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) Trading Down 6.3% - What's Next?July 8, 2026 | marketbeat.comSimplify Asset Management Inc. Sells 109,512 Shares of Warby Parker Inc. $WRBYJuly 4, 2026 | marketbeat.comNeil Harris Blumenthal Sells 217,667 Shares of Warby Parker (NYSE:WRBY) StockJuly 4, 2026 | americanbankingnews.comWarby Parker (NYSE:WRBY) CEO Sells 217,667 SharesJuly 3, 2026 | insidertrades.comInsider Selling: Warby Parker (NYSE:WRBY) CEO Sells 217,667 SharesJuly 2, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) CEO Sells $1,090,452.00 in StockJuly 2, 2026 | insidertrades.comNeil Harris Blumenthal Sells 36,300 Shares of Warby Parker (NYSE:WRBY) StockJuly 1, 2026 | marketbeat.comSG Americas Securities LLC Invests $2.71 Million in Warby Parker Inc. $WRBYJuly 1, 2026 | marketbeat.comWarby Parker disrupts eyewear industry with full-service eyewear retailer — BofAJune 29, 2026 | seekingalpha.comWarby Parker Has 'Plenty More Than Meets The Eye', Analyst SaysJune 29, 2026 | benzinga.comWarby Parker (NYSE:WRBY) Coverage Initiated by Analysts at Bank of AmericaJune 29, 2026 | marketbeat.comMaridea Wealth Management LLC Raises Holdings in Warby Parker Inc. $WRBYJune 27, 2026 | marketbeat.comWhat Does the Sale of Warby Parker Shares Worth $1.9 Million by the Co-CEO Mean for Investors?June 25, 2026 | fool.comVaughan Nelson Investment Management L.P. Purchases 722,627 Shares of Warby Parker Inc. $WRBYJune 22, 2026 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Given Average Rating of "Moderate Buy" by AnalystsJune 21, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) Director Sells 5,000 SharesJune 19, 2026 | insidertrades.comWarby Parker (WRBY) Unveils First Line of Intelligent Eyewear Powered by Gemini and Android XRJune 19, 2026 | uk.finance.yahoo.comClough Capital Partners L P Makes New $1.57 Million Investment in Warby Parker Inc. $WRBYJune 18, 2026 | marketbeat.com393,085 Shares in Warby Parker Inc. $WRBY Acquired by Atreides Management LPJune 18, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026The Oil Trade May Not Be Over: 3 Energy Stocks to WatchBy Thomas Hughes | June 21, 2026Qualcomm Goes All-In: The $10B Bet to Crush NVIDIABy Jeffrey Neal Johnson | June 18, 2026BVS, IRTC, WRBY, and ESTA Company DescriptionsBioventus NASDAQ:BVS$11.56 -0.51 (-4.23%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$11.68 +0.13 (+1.08%) As of 04:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.Establishment Labs NASDAQ:ESTA$86.59 -1.31 (-1.49%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$86.85 +0.26 (+0.30%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.iRhythm Technologies NASDAQ:IRTC$112.55 -6.13 (-5.17%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$112.49 -0.06 (-0.05%) As of 04:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Warby Parker NYSE:WRBY$27.65 +0.24 (+0.87%) Closing price 07/14/2026 03:59 PM EasternExtended Trading$27.65 +0.00 (+0.00%) As of 04:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet 3 Overlooked Energy ETFs Delivering Strong Returns and Income 3 Space Stocks That Could Outshine SpaceX After Its IPO 3 Energy Stocks Racing to Fix AI's Power Problem JPMorgan’s Q2 Strength Gives the Stock Rally New Support No Space For Panic: T-Mobile Shrugs Off The Starlink Threat Prepare for the Next Wave of Factory Automation With These 3 Standout Names Wedbush Pounds the Table—Buy Sandisk Before August 5 Earnings Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
